Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Randomized Study to Evaluate the Efficacy of Apixaban and Clopidogrel on the Prevention of Recurrent Ischemic Stroke in Patients With Atrial Fibrillation and Cerebral Atherosclerosis

NCT07237308 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07237308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Randomized Study to Evaluate the Efficacy of Apixaban and Clopidogrel on the Prevention of Recurrent Ischemic Stroke in Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
October 31, 2029
Enrollment
586 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, atrial fibrillation, intracrnaial arterioscelrosis, ischemic, stroke